Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald J Buchsbaum

Showing results (61-70 of 157) with videos related to

Pageof 16
Sort By:
Ecancermedicalscience|September 6, 2016
Role of nanotechnology and gene delivery systems in TRAIL-based therapiesGeorge E Naoum, Fady Tawadros, Ammad Ahmad Farooqi, et al.
Cancer Research|January 30, 2013
ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell linesAmanda F Swindall, Angelina I Londoño-Joshi, Matthew J Schultz, et al.
Molecular Cancer Therapeutics|September 16, 2008
Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase geneLyudmila N Kaliberova, Debbie L Della Manna, Valentina Krendelchtchikova, et al.
Cancer|March 6, 2002
Model prediction of treatment planning for dose-fractionated radioimmunotherapySui Shen, Jun Duan, Ruby F Meredith, et al.
Gynecologic Oncology|November 8, 2005
Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer modelJ Michael Straughn, Patsy G Oliver, Tong Zhou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cellsSergey A Kaliberov, Donald J Buchsbaum, G Yancey Gillespie, et al.
Molecular Cancer Therapeutics|November 6, 2009
Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expressionLyudmila N Kaliberova, Sergei A Kusmartsev, Valentina Krendelchtchikova, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 20, 2014
Pazopanib combined with radiation: in vivo model of interactionRuby F Meredith, Kevin P Raisch, James A Bonner, et al.
Nuclear Medicine and Biology|April 30, 2018
Corrigendum to '<sup>212</sup>Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models' [Nucl Med Biol 58 (2018) 67-73]Benjamin B Kasten, Abhishek Gangrade, Harrison Kim, et al.
Nuclear Medicine and Biology|February 8, 2018
<sup>212</sup>Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse modelsBenjamin B Kasten, Abhishek Gangrade, Harrison Kim, et al.
Pageof 16

Showing results (61-70 of 157) with videos related to

Sort By:
Pageof 16
Ecancermedicalscience|September 6, 2016
Role of nanotechnology and gene delivery systems in TRAIL-based therapiesGeorge E Naoum, Fady Tawadros, Ammad Ahmad Farooqi, et al.
Cancer Research|January 30, 2013
ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell linesAmanda F Swindall, Angelina I Londoño-Joshi, Matthew J Schultz, et al.
Molecular Cancer Therapeutics|September 16, 2008
Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase geneLyudmila N Kaliberova, Debbie L Della Manna, Valentina Krendelchtchikova, et al.
Cancer|March 6, 2002
Model prediction of treatment planning for dose-fractionated radioimmunotherapySui Shen, Jun Duan, Ruby F Meredith, et al.
Gynecologic Oncology|November 8, 2005
Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer modelJ Michael Straughn, Patsy G Oliver, Tong Zhou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cellsSergey A Kaliberov, Donald J Buchsbaum, G Yancey Gillespie, et al.
Molecular Cancer Therapeutics|November 6, 2009
Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expressionLyudmila N Kaliberova, Sergei A Kusmartsev, Valentina Krendelchtchikova, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 20, 2014
Pazopanib combined with radiation: in vivo model of interactionRuby F Meredith, Kevin P Raisch, James A Bonner, et al.
Nuclear Medicine and Biology|April 30, 2018
Corrigendum to '<sup>212</sup>Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models' [Nucl Med Biol 58 (2018) 67-73]Benjamin B Kasten, Abhishek Gangrade, Harrison Kim, et al.
Nuclear Medicine and Biology|February 8, 2018
<sup>212</sup>Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse modelsBenjamin B Kasten, Abhishek Gangrade, Harrison Kim, et al.
Pageof 16